Erasca to discuss phase 1 data for RAS cancer drug ERAS-0015
Tweet Send to a Friend
Erasca Inc. (NASDAQ: ERAS) announced it will host a conference call and webcast on April 27, 2026, at 4:30 p.m ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


